Help Protect & Advance
Freedom of Thought!


DonateNow
 

 

 

 

Subscribe to E-Mail News
from the CCLE.

 

 

 

 

 

CCLE MAJOR ACHIEVEMENTS

Below is a listing of our major achievements from our founding in January 2000. You may also be interested in our Mission Statement.

View Recent Achievements

Click the year below to read earlier year's major achievements.

2004 | 2003 | 2002 | 2001 | 2000


2004 CCLE Major Achievements
Online here.

2003 CCLE MAJOR ACHIEVEMENTS

Submitted amicus curiae legal brief in United States Supreme Court Case of Sell v. United States in support of Dr. Sell’s effort to avoid forced-drugging with psychoactive drugs. Case decided in June 2003, with legal victory for Dr. Sell.

CCLE submitted written testimony to the American Bar Association's Kennedy Commission on the topic of reducing or eliminating mandatory minimum sentences for nonviolent drug offenses.

Initiated a Mental Diversity Scholarship Fund, and made first four awards.

CCLE prepared reports of the cognitive liberty implications of state marijuana laws, and submitted these reports to a total of 429 state legislators in fifteen states. Our reports were also presented to the press, by way of 234 press releases.

CCLE submitted written testimony to the Drug Enforcement Administration objecting to the scheduling of three new drugs.

The CCLE sent our Salvia divinorum report to all members of the Oregon Judiciary Committee, considering two bills related to the psychoactive plant Salvia divinorum. Both bill's died in that committee upon adjournment.

Welcomed Kevin Feeney as our 2003 Summer Fellow.

Published two more issues of our redesigned Journal of Cognitive Liberties.

Sponsored and presented at the National Science Foundation’s Nano-Bio-Info-Cogni Convergence Conference.

Logged 51 presentations and press publications.


2002 CCLE MAJOR ACHIEVEMENTS
A more detailed Annual Report for 2002 is also available as a large 610kb pdf.

CCLE presented written and spoken testimony on the topic of brain enhancement to the President’s Council on Bioethics in Washington D.C. In October 2003, the Council issued its report "Beyond Therapy: Biotechnology and the Pursuit of Happiness." 

The California Legislature considered a bill (SB 1103) that would have imposed a 90-day mandatory minimum sentence for using or being under the influence of MDMA (Ecstasy). After preparing an analysis of this bill for the members of California’s Public Safety Committee, CCLE legal counsel Richard Glen Boire presented spoken testimony before the Committee explaining how the mandatory minimum infringed upon the cognitive liberty of adults and, rather than protect young people, would tear them from their families and disrupt their education. At the end of the hearing, the bill was defeated by a 3-2 vote.

In 2002, approximately 75,000 people visited Ask Dr. Shulgin Online, submitting hundreds of questions. Ask Dr. Shulgin Online was mentioned on National Public Radio, and discussed in newspaper and magazine articles around the world, encouraging continued public debate about effective drug education and the negative consequences of drug prohibition.

The CCLE provided research and other information concerning, MDMA and founding father’s devotion to “the pursuit of happiness” to Peter Jennings and Todd Brewster, authors of In Search of America, an ABC News Special and book. The book, published in September, includes a section on “Fighting for the right to pursue happiness.”

The US Congress considered placing Salvia divinorum into Schedule I of the federal Controlled Substances Act. (See CCLE archive on HR 5607). CCLE sent key members of the US Congress our report on Salvia divinorum and its active principle, along with letters from an array of scientists who expressed concern that scheduling salvia divinorum would negatively impact important research on the plant. HR 5607 failed to pass before Congress adjourned at the end of 2002.

The CCLE submitted written comments to the DEA objecting to the scheduling of the drug 2C-T-7.

Logged 43 presentations and press publications.

Welcomed me:me sous rapture as our 2002 Summer Fellow.

As part of our Summer Fellows’ Program, the CCLE began creating a rigorous cognitive liberty curriculum for university professors (educators) and student groups interested in teaching a course on cognitive liberty. This curriculum is freely available on the CCLE Web site [link], and is mailed to interested teachers and students at cost. The curriculum was unveiled in September 2002 and quickly generated interest from students and professors at universities across North America.

The CCLE filed a “friend of the court” legal brief in the United States Supreme Court, arguing that the Court should review the case of Dr. Thomas Sell, and block government efforts to forcibly inject the St. Louis dentist with mind altering drugs. The U.S Supreme Court accepted the case for review in November 2002, and decided the case in favor of Dr. Sell in June 2003.

The CCLE’s reports and analysis were relayed and relied upon by the Drug Reform Coordination Network, the Drug Policy Alliance, and the American Bar Association.

In 2002, we published 3 more issues of our Journal of Cognitive Liberties and were pleased to become a member of the International Consortium for the Advancement of Academic Publishing (ICAAP), a prestigious association of publishers of scholarly journals available online.


2001 CCLE MAJOR ACHIEVEMENTS
A more detailed report for 2001 is also available as a 49 kb pdf.

After the US Sentencing Commission issues a ten-day notice of its intent to increase significantly MDMA sentences CCLE coordinated public comments to Sentencing Commission, submitting 277 pages of written comments, and requesting a public hearing (granted). (In its final report to Congress, the Sentencing Commission notes: "the volume of public comment received on the proposed changes to the guidelines for MDMA trafficking far exceeds that for any issue this Commission has addressed since taking office in November 1999.")

CCLE coordinates and presents written and spoken testimony before the US Sentencing Commission arguing that raising federal punishment for MDMA offenses will increase individual and social harm. In its final report, the Sentencing Commission recommends that Congress raise punishment, but the proposed increase is 50% less than initially proposed.

Initiated a CCLE Summer Fellows Program, and welcomed Adam Fish as our 2001 Summer Fellow.

Initiated Ask Dr. Shulgin Online, an extremely popular, free, and anonymous online drug education project that provides honest, nonjudgmental, and accurate information about psychoactive drugs.

Initiated Salvia Divinorum Action Center and Salvia Divinorum Defense Fund [link] to provide balanced information about the plant and its active principles to the press and policymakers. Prepared a CCLE Report on the plant in collaboration with other experts, and submitted this report to the Drug Enforcement Administration’s Drug and Chemical Evaluation Section.

Produced public service announcements (PSAs) for 380 college and independent radio stations in the United States.

Produced and disseminations over 8,000 cognitive liberty pamphlets, stickers and flyers.

Published 3 more issues of our Journal of Cognitive Liberties.

Logged numerous presentations and press publications.


2000 CCLE MAJOR ACHIEVEMENTS

Founded the Center for Cognitive Liberty & Ethics (January 2000)!

Established a Board of Advisors.

Published three issues of our Journal of Cognitive Liberties.

Became first organization to publicize new federal bill – The Ecstasy Anti-Proliferation Act of 2000 - which sought to significantly increase punishment for federal MDMA (ecstasy) offenses, and to prohibit certain discussions about the drug. The CCLE produced and distributed a legal analysis of the bill to the press, other organizations, and to members of the Senate Judiciary Committee. Bill passes in September 2000 with lesser increase in punishment and without the ban on information.

The CCLE submitted written testimony to the Food and Drug Administration and the World Health Organization contesting the addition of three more substances to international control.